首页> 外国专利> methods for providing adjuvant treatment to a patient with an earlier diagnosis of melanoma that has been resected and to increase relapse-free survival (rfs) of a patient following melanoma resection;

methods for providing adjuvant treatment to a patient with an earlier diagnosis of melanoma that has been resected and to increase relapse-free survival (rfs) of a patient following melanoma resection;

机译:为已经被切除的黑色素瘤的较早诊断的患者提供辅助治疗的方法,以及增加黑色素瘤切除后患者的无复发生存率的方法;

摘要

1/1 summary â € œmethods to provide adjunctive treatment to a patient with an earlier diagnosis of melanoma that has been resected and to increase a patientâ € ™ s non-relapsing survival (rfs) after melanoma resection, and, composition. The present invention relates to a method of providing adjuvant treatment to a human patient which comprises administering to a patient as such therapeutically effective doses of dabrafenib and trametinib for a period of time sufficient to increase survival without relapse (rfs).
机译:1/1摘要–为已被切除的黑色素瘤的早期诊断的患者提供辅助治疗的方法,并增加黑色素瘤切除及其组成后患者的非复发生存率(rfs)。本发明涉及一种为人类患者提供辅助治疗的方法,该方法包括向患者施用治疗有效剂量的达布拉非尼和曲美替尼一段足以增加生存而不复发的时间(rfs)。

著录项

  • 公开/公告号BR112015004578A2

    专利类型

  • 公开/公告日2017-07-04

    原文格式PDF

  • 申请/专利权人 GLAXOSMITHKLINE LLC;

    申请/专利号BR20151104578

  • 发明设计人 PETER F. LEBOWITZ;SYLVIE LAQUERRE;

    申请日2013-08-30

  • 分类号A61K31/506;A61K31/519;A61P35;

  • 国家 BR

  • 入库时间 2022-08-21 13:40:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号